Shell Asset Management Co
- SEC CIK
- 0001211028
- Latest filing
- Nov 7, 2025
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q3 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −320−100.0% | Sold out | Holders |
| Q2 2025 | 320 | $3.00K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 6,401 | $3.00K | <0.1% | −6,409−50.0% | Reduced | Holders |
| Q4 2024 | 12,810 | $8.00K | <0.1% | −115,175−90.0% | Reduced | Holders |
| Q3 2024 | 127,985 | $177.0K | <0.1% | – | No prior filing | Holders |
| Q2 2024 | – | – | – | – | Not filed | Holders |
| Q1 2024 | 130,727 | $190.0K | <0.1% | −13,264−9.2% | Reduced | Holders |
| Q4 2023 | 143,991 | $279.0K | <0.1% | −43,172−23.1% | Reduced | Holders |
| Q3 2023 | 187,163 | $275.0K | <0.1% | −3,243−1.7% | Reduced | Holders |
| Q2 2023 | 190,406 | $605.0K | <0.1% | +190,406 | New | Holders |